| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/26/2011 | US20110125235 Indwelling heat exchange catheter and method of using same |
| 05/26/2011 | US20110125109 Wound stick |
| 05/26/2011 | US20110125089 Hemostatic microspheres |
| 05/26/2011 | US20110124720 Compositions and methods for treating immune disorders |
| 05/26/2011 | US20110124696 Sulfone Compounds Which Modulate The CB2 Receptor |
| 05/26/2011 | US20110124675 The hydrosulfate of prasugrel, its pharmaceutical combination and use thereof |
| 05/26/2011 | US20110124658 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 05/26/2011 | US20110124565 Modified Coagulation Factor VIII With Enhanced Stability and Its Derivatives |
| 05/26/2011 | US20110124558 Novel uses of d-mannopyranose derivatives activating angiogenesis |
| 05/26/2011 | US20110124551 Formulations of daptomycin |
| 05/26/2011 | US20110123702 Room temperature-curable polymers |
| 05/26/2011 | US20110123651 Dietary supplement drink for delivery of resveratrol and other polyphenols |
| 05/26/2011 | US20110123646 Extracts Obtained from Cell Line Cultures from Plants Belonging to the Oleaceae Family (e.g. Syringa Vulgaris), Their Preparation and Use |
| 05/26/2011 | US20110123635 Method for manufacturing medicinal compounds containing dabigatran |
| 05/26/2011 | US20110123624 Formulations comprising aminosterols |
| 05/26/2011 | US20110123619 Buccal delivery system |
| 05/26/2011 | US20110123615 Solid pharmaceutical composition |
| 05/26/2011 | US20110123606 Oral composition containing an antiplatelet agent of the thienopyridine family in the form of free base |
| 05/26/2011 | US20110123544 Human antibodies that bind human il-12 and methods for producing |
| 05/26/2011 | US20110123517 Dissolvable pharmaceutical implant |
| 05/26/2011 | US20110123502 Method for obtaining treg-cells |
| 05/26/2011 | US20110123484 Methods and compositions for treating fus1 related disorders |
| 05/26/2011 | US20110123481 Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications |
| 05/26/2011 | US20110123479 Medical adhesives for stopping heavy bleeding and sealing leakages |
| 05/26/2011 | CA2780150A1 Substituted carbamoylmethylamino acetic acid derivatives as novel nep inhibitors |
| 05/25/2011 | EP2325317A1 Receptor nucleic acids and polypeptides |
| 05/25/2011 | EP2325193A2 Methods and compositions for therapeutic use of RNA interference |
| 05/25/2011 | EP2325187A1 The hydrosulfate of prasugrel, its pharmaceutical combination and uses thereof |
| 05/25/2011 | EP2324861A1 In vivo use of water absorbent polymers |
| 05/25/2011 | EP2324851A1 Methods of administering anti-TNFalpha antibodies |
| 05/25/2011 | EP2324839A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 05/25/2011 | EP2324835A2 Composition of dialysis liquid comprising crystallisation inhibitor substances |
| 05/25/2011 | EP2324834A2 Methods of Increasing Endogenous Erythropoietin (EPO) |
| 05/25/2011 | EP2324825A1 Aryl ureas with angiogenesis inhibiting activity |
| 05/25/2011 | EP2323694A1 Conjugated proteins with prolonged in vivo efficacy |
| 05/25/2011 | EP1894576B1 Novel triglyceride reducing agent |
| 05/25/2011 | EP1536823B1 Use of erythopoietin |
| 05/25/2011 | EP1317454B1 Caspase inhibitors and uses thereof |
| 05/25/2011 | EP1267942B1 Chemically modified novel erythropoietin stimulating protein compositions and methods |
| 05/25/2011 | EP1263463B1 Use of an antibody or an immunotoxin that selectively binds to cd123 to impair hematologic cancer progenitor cells |
| 05/25/2011 | CN1772897B Cell factor with several functions |
| 05/25/2011 | CN102076852A Modulation of factor 7 expression |
| 05/25/2011 | CN102076699A Hydrogensulfate salt of 2-acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine and its preparation |
| 05/25/2011 | CN102076698A 2h- pyrimido [2, 1-b] quinaz0lin-2-0ne derivatives and their use as platelet anti-aggregative agents |
| 05/25/2011 | CN102076697A Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases |
| 05/25/2011 | CN102076696A Substituted quinazolines |
| 05/25/2011 | CN102076695A Imidazoquinazoline derivatives as anagrelide analogues for the treatment of myeloprolific diseases and thrombotic diseases |
| 05/25/2011 | CN102076687A Substituted quinazolines as blood platelet lowering agents |
| 05/25/2011 | CN102076685A Substituted quinazolines |
| 05/25/2011 | CN102076680A Benzoimidazoles as prolyl hydroxylase inhibitors |
| 05/25/2011 | CN102076668A Substituted quinazolines |
| 05/25/2011 | CN102076650A Carboxylic acid compound |
| 05/25/2011 | CN102071184A Tabanusyao Macquart antithrombotic enzyme tablysin and gene and application thereof |
| 05/25/2011 | CN102070715A Human antibodies that bind human TNF alpha |
| 05/25/2011 | CN102070605A Imatinib mesylate polymorph and pharmaceutical composition |
| 05/25/2011 | CN102070595A Substituted benzoxanthone type compound and application thereof |
| 05/25/2011 | CN102068686A New application of interleukin-12 |
| 05/25/2011 | CN102068636A Herbal preparation for treating ascitic type liver cancer |
| 05/25/2011 | CN102068607A Chinese medicinal preparation for treating leukopenia and stomach upset caused by radiotherapy and chemotherapy |
| 05/25/2011 | CN102068604A Modified angelica sinensis blood enriching preparation and application and preparation method thereof |
| 05/25/2011 | CN102068581A Chinese medicinal formula for treating allergic purpura |
| 05/25/2011 | CN102068542A Medicament for treating hemorrhage disease of grass carp |
| 05/25/2011 | CN102068459A Enteric coatel tablet taking leech as raw material |
| 05/25/2011 | CN102068456A Chinese medicinal plaster for treating malignant blood diseases |
| 05/25/2011 | CN102068450A Application of aucubin to preparation of anti-thrombosis medicament |
| 05/25/2011 | CN102068419A Curcumin composition |
| 05/25/2011 | CN101843594B Alprostadil freeze-dried emulsion for injection and preparation method thereof |
| 05/25/2011 | CN101703648B Chinese patent medicament for treating hematochezia and preparation method thereof |
| 05/25/2011 | CN101632803B Stancher and preparation method thereof |
| 05/25/2011 | CN101560244B New method for synthesizing argatroban by combining solid phase method and liquid phase method |
| 05/25/2011 | CN101554373B Caffeic acid composition and preparation method thereof |
| 05/25/2011 | CN101481692B Non-blood serum preparation of recombinant human blood coagulation factor IX |
| 05/25/2011 | CN101444629B Non-injection gene therapy medicine and medicine box thereof |
| 05/25/2011 | CN101420946B Tamsulosin-containing percutaneous absorption type preparation |
| 05/25/2011 | CN101361839B Quality control detection method of Xuefu Zhuyu oral liquid |
| 05/25/2011 | CN101278971B Chinese medicinal composition for curing puffiness and edema |
| 05/25/2011 | CN101239120B Yixueling tablet |
| 05/25/2011 | CN101237870B Concomitant pharmaceutical agents and use thereof |
| 05/25/2011 | CN101185759B Anti-angiogene compositions and methods of use |
| 05/25/2011 | CN101056662B Adhesion preventive material and method of preventing adhesion |
| 05/24/2011 | US7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 05/24/2011 | US7947472 An expression vector comprising a sequence of human DNA encoding vascular endothelial growth factor-D (VEGF-D) or a fragment having the biological activity of VEGF-D, inserted into a mammalian expression vector |
| 05/24/2011 | US7947282 Methods of treatment using vascular occlusion in combination therapies |
| 05/24/2011 | CA2490239C Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors |
| 05/24/2011 | CA2477601C 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 05/24/2011 | CA2453901C Substituted 4-aminocyclohexanols |
| 05/24/2011 | CA2443952C Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
| 05/24/2011 | CA2393710C Caspase inhibitors and uses thereof |
| 05/24/2011 | CA2339487C Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells |
| 05/24/2011 | CA2266640C Methods for treating an ischemic disorder and improving stroke outcome |
| 05/19/2011 | WO2011059080A1 Isotope-substituted diamine derivative |
| 05/19/2011 | WO2011059021A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 05/19/2011 | WO2011058473A1 N2-pyrazolospiroketone acetyl-coa carboxylase inhibitors |
| 05/19/2011 | WO2011018582A3 Floating microgranules |
| 05/19/2011 | WO2011006072A3 Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia |
| 05/19/2011 | WO2010131910A9 Composition for improving blood circulation containing fermented tea, and pharmaceutical and health-food compositions comprising the same |
| 05/19/2011 | US20110118825 Anti-angiogenic compositions and methods of use |
| 05/19/2011 | US20110118282 Soluble Guanylate Cyclase Activators |
| 05/19/2011 | US20110118188 Factor viii polypeptide having factor viii:c activity |
| 05/19/2011 | US20110118187 Reversible platelet inhibition |